Company No: 13183135 (England and Wales)

Contents

• Company Information
• Balance Sheet
• Notes to the Financial Statements

DIRECTORS	Mr Gary Dickenson
	Dr Mark Skimming

REGISTERED OFFICE

United Kingdom

COMPANY NUMBER

13183135 (England and Wales)

ACCOUNTANT	Inglis Chartered Accountants
	Wellington House
	Aviator Court
	York
	YO30 4UZ
	United Kingdom

	Note	2025		2024
		£		£
Fixed assets
Tangible assets	3	121,244		161,658
		121,244		161,658
Current assets
Debtors	4	95,686		21,927
Cash at bank and in hand	5	4,170		10,026
		99,856		31,953
Creditors: amounts falling due within one year	6	( 411,623)		( 386,009)
Net current liabilities		(311,767)		(354,056)
Total assets less current liabilities		(190,523)		(192,398)
Net liabilities		( 190,523)		( 192,398)
Capital and reserves
Called-up share capital	8	100		100
Profit and loss account		( 190,623 )		( 192,498 )
Total shareholders' deficit		( 190,523)		( 192,398)

For the financial year ending 31 July 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• The members have not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
• The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements; and
• These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and a copy of the Profit and Loss Account has not been delivered.

The financial statements of Smilefast Implants Ltd (registered number: 13183135) were approved and authorised for issue by the Board of Directors on 29 April 2026. They were signed on its behalf by:

Mr Gary Dickenson Director

1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Smilefast Implants Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is , United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Plant and machinery	25 % reducing balance
Computer equipment	25 % reducing balance

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account as described below.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Ordinary share capital

The ordinary share capital of the Company is presented as equity.

2. Employees

	2025		2024
	Number		Number
Monthly average number of persons employed by the Company during the year, including directors	3		3

3. Tangible assets

	Plant and machinery		Computer equipment		Total
	£		£		£
Cost
At 01 August 2024	73,802		259,308		333,110
At 31 July 2025	73,802		259,308		333,110
Accumulated depreciation
At 01 August 2024	34,354		137,098		171,452
Charge for the financial year	9,862		30,552		40,414
At 31 July 2025	44,216		167,650		211,866
Net book value
At 31 July 2025	29,586		91,658		121,244
At 31 July 2024	39,448		122,210		161,658

4. Debtors

	2025		2024
	£		£
Trade debtors	29,579		21,927
Deferred tax asset	66,107		0
	95,686		21,927

5. Cash and cash equivalents

	2025		2024
	£		£
Cash at bank and in hand	4,170		10,026

6. Creditors: amounts falling due within one year

	2025		2024
	£		£
Trade creditors	37,109		86,040
Amounts owed to Group undertakings	229,400		157,900
Other taxation and social security	4		9,818
Other creditors	145,110		132,251
	411,623		386,009

7. Deferred tax

	2025		2024
	£		£
At the beginning of financial year	0		0
Credited to the Profit and Loss Account	66,107		0
At the end of financial year	66,107		0

8. Called-up share capital

	2025		2024
	£		£
Allotted, called-up and fully-paid
100 Ordinary shares of £ 1.00 each	100		100